Skip to main content
Erschienen in: DNP - Der Neurologe & Psychiater 6/2015

29.05.2015 | Literatur kompakt

Neue Studien zur Behandlung der Zwangsstörung

verfasst von: Prof. Dr. med. Ulrich Voderholzer, PD Dr. med. Rebecca Schennach

Erschienen in: DNP – Die Neurologie & Psychiatrie | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Zwangsstörung ist nach der jüngsten epidemiologischen Studie in Deutschland die vierthäufigste psychische Störung [1]. Dieser Beitrag fasst einige, für die Praxis relevante, neue Veröffentlichungen zu diesem Krankheitsbild zusammen.
Literatur
1.
Zurück zum Zitat Jacobi F et al. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: The mental health module of the German health interview and examination survey for adults (DEGS1-MH). Int J Methods in Psychiatr Res 2014; 23 (3): 304–19CrossRef Jacobi F et al. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: The mental health module of the German health interview and examination survey for adults (DEGS1-MH). Int J Methods in Psychiatr Res 2014; 23 (3): 304–19CrossRef
2.
3.
Zurück zum Zitat Meyer JM et al. Why do clinicians exclude anxious clients from exposure therapy? Behav Res Ther 2014; 54: 49–53CrossRefPubMed Meyer JM et al. Why do clinicians exclude anxious clients from exposure therapy? Behav Res Ther 2014; 54: 49–53CrossRefPubMed
4.
Zurück zum Zitat Torp NC et al. Effectiveness of cognitive behavior treatment for pediatric obsessive-compulsive disorder: Acute outcomes from the Nordic Long-term OCD Treatment Study (NordLOTS). Behav Res Ther 2015; 64: 15–23CrossRefPubMed Torp NC et al. Effectiveness of cognitive behavior treatment for pediatric obsessive-compulsive disorder: Acute outcomes from the Nordic Long-term OCD Treatment Study (NordLOTS). Behav Res Ther 2015; 64: 15–23CrossRefPubMed
5.
Zurück zum Zitat Goetter EM et al. An open trial of videoconference-mediated exposure and ritual prevention for obsessive-compulsive disorder. J Anxiety Disord 2014; 28: 460–2CrossRefPubMed Goetter EM et al. An open trial of videoconference-mediated exposure and ritual prevention for obsessive-compulsive disorder. J Anxiety Disord 2014; 28: 460–2CrossRefPubMed
6.
Zurück zum Zitat Vogel PA et al. A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behav Res Ther 2014; 63: 162–8CrossRef Vogel PA et al. A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behav Res Ther 2014; 63: 162–8CrossRef
7.
Zurück zum Zitat Andersson E et al. Long-term efficacy of Internet-based cognitive behavior therapy for obsessive-compulsive disorder with or without booster: a randomized controlled trial. Psychological Medicine 2014; 44: 2877–87CrossRefPubMed Andersson E et al. Long-term efficacy of Internet-based cognitive behavior therapy for obsessive-compulsive disorder with or without booster: a randomized controlled trial. Psychological Medicine 2014; 44: 2877–87CrossRefPubMed
8.
Zurück zum Zitat Külz AK et al. Achtsamkeitsbasierte kognitive Therapie (MBCT) zur Behandlung von Zwangsstörungen. Verhaltenstherapie und Psychosoziale Praxis 2013; 45: 327–44 Külz AK et al. Achtsamkeitsbasierte kognitive Therapie (MBCT) zur Behandlung von Zwangsstörungen. Verhaltenstherapie und Psychosoziale Praxis 2013; 45: 327–44
9.
Zurück zum Zitat Bluett EJ et al. Acceptance and commitment therapy for anxiety and OCD spectrum disorders: An empirical review. J Anxiety Disord 2014; 28: 612–24CrossRefPubMed Bluett EJ et al. Acceptance and commitment therapy for anxiety and OCD spectrum disorders: An empirical review. J Anxiety Disord 2014; 28: 612–24CrossRefPubMed
10.
Zurück zum Zitat Külz A et al. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial. BMC Psychiatry. 2014; 14: 314CrossRefPubMedCentralPubMed Külz A et al. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial. BMC Psychiatry. 2014; 14: 314CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Rector NA et al. Pilot Test of the Additive Benefits of Physical Exercise to CBT for OCD. Cogn Behav Ther 2015; 4: 1–13CrossRef Rector NA et al. Pilot Test of the Additive Benefits of Physical Exercise to CBT for OCD. Cogn Behav Ther 2015; 4: 1–13CrossRef
12.
Zurück zum Zitat Thompson-Hollands J et al. Family involvement in the psychological treatment of obsessive-compulsive disorder: a meta-analysis. J Fam Psychol. 2014; 28: 287–98CrossRefPubMed Thompson-Hollands J et al. Family involvement in the psychological treatment of obsessive-compulsive disorder: a meta-analysis. J Fam Psychol. 2014; 28: 287–98CrossRefPubMed
13.
Zurück zum Zitat Leopold R, Backenstrass M. Neuropsychological differences between obsessive-compulsive washers and checkers: A systematic review and meta-analysis. J Anxiety Disord 2015; 30C: 48–58CrossRef Leopold R, Backenstrass M. Neuropsychological differences between obsessive-compulsive washers and checkers: A systematic review and meta-analysis. J Anxiety Disord 2015; 30C: 48–58CrossRef
14.
Zurück zum Zitat Veale D et al. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. BMC Psychiatry 2014; 14: 317CrossRefPubMedCentralPubMed Veale D et al. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. BMC Psychiatry 2014; 14: 317CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Simpson HB et al. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: A randomized clinical trial. JAMA Psychiatry 2013; 70 (11): 1190–8CrossRefPubMedCentralPubMed Simpson HB et al. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: A randomized clinical trial. JAMA Psychiatry 2013; 70 (11): 1190–8CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Miodownik C et al. Amisulpride as Add-on Treatment for Resistant Obsessive-Compulsive Disorder: Retrospective Case Series. Clin Neuropharmacol 2015; 38 (1): 26–9CrossRefPubMed Miodownik C et al. Amisulpride as Add-on Treatment for Resistant Obsessive-Compulsive Disorder: Retrospective Case Series. Clin Neuropharmacol 2015; 38 (1): 26–9CrossRefPubMed
17.
Zurück zum Zitat Grant PJ et al. 12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder. Neuropsychopharmacology 2014; 39: 1453–9CrossRefPubMedCentralPubMed Grant PJ et al. 12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder. Neuropsychopharmacology 2014; 39: 1453–9CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Islam L et al. Deep brain stimulation of the nucleus accumbens and bed nucleus of stria terminalis for obsessive-compulsive disorder: A Case Series. World Neurosurg 2015; 83 (4): 657–63CrossRefPubMed Islam L et al. Deep brain stimulation of the nucleus accumbens and bed nucleus of stria terminalis for obsessive-compulsive disorder: A Case Series. World Neurosurg 2015; 83 (4): 657–63CrossRefPubMed
Metadaten
Titel
Neue Studien zur Behandlung der Zwangsstörung
verfasst von
Prof. Dr. med. Ulrich Voderholzer
PD Dr. med. Rebecca Schennach
Publikationsdatum
29.05.2015
Verlag
Urban & Vogel
Erschienen in
DNP – Die Neurologie & Psychiatrie / Ausgabe 6/2015
Print ISSN: 2731-8168
Elektronische ISSN: 2731-8176
DOI
https://doi.org/10.1007/s15202-015-0814-5

Weitere Artikel der Ausgabe 6/2015

DNP - Der Neurologe & Psychiater 6/2015 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie